RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.34
-0.04 (-10.53%)
Open$0.35
Previous Close$0.38
Day High$0.40
Day Low$0.31
52W High$15.40
52W Low$0.26
Volume—
Avg Volume25.8K
Market Cap4.59M
P/E Ratio—
EPS$-1.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,538.2% upside
Current
$0.34
$0.34
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 8.56M | 9.00M |
| Net Income | 1.57M | 1.65M | 1.70M |
| Profit Margin | 18.8% | 19.3% | 18.9% |
| EBITDA | 1.64M | 1.79M | 2.00M |
| Free Cash Flow | 1.45M | 1.55M | 1.35M |
| Rev Growth | +3.9% | +2.6% | +16.0% |
| Debt/Equity | 0.31 | 0.31 | 0.40 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |